Clinical Trial Update: Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2) [Phase 2]

View source ↗

Summary

This update covers the Phase 2 trial ZUPREME 2 evaluating Petrelintide for people who are overweight or have obesity with type 2 diabetes, focusing on efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Petrelintide (Petrelintide)

Snippet

Sponsor: Zealand Pharma | Conditions: Overweight, Type 2 Diabetes | Phase 2 | Status: ACTIVE_NOT_RECRUITING